← All published screens
Highest ROE in Healthcare
Snapshot from 2026-08-02 · 25 stocks
Sector is Healthcare
| Ticker | Name | Sector | Price | Market Cap | P/E | P/B | ROE | Gross Margin |
|---|---|---|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics, Inc. - Common Stock | Healthcare | $82.54 | $9.79B | 30.90 | 44.58 | 144.3% | — |
| AVAH | Aveanna Healthcare Holdings Inc. - Common Stock | Healthcare | $9.39 | $2.04B | 9.09 | 8.52 | 93.7% | — |
| AUPH | Aurinia Pharmaceuticals Inc - Common Shares | Healthcare | $14.88 | $1.91B | 6.66 | 3.37 | 50.6% | — |
| EXEL | Exelixis, Inc. - Common Stock | Healthcare | $53.03 | $13.33B | 17.03 | 6.89 | 40.4% | — |
| MRK | Merck & Company, Inc. Common Stock (new) | Healthcare | $130.20 | $321.57B | 17.62 | 7.01 | 39.8% | — |
| ALNY | Alnylam Pharmaceuticals, Inc. - Common Stock | Healthcare | $205.52 | $27.26B | 86.87 | 34.54 | 39.8% | — |
| TMDX | TransMedics Group, Inc. - Common Stock | Healthcare | $76.51 | $2.64B | 13.90 | 5.35 | 38.5% | — |
| CRMD | CorMedix Inc. - Common Stock | Healthcare | $7.53 | $590.74M | 3.62 | 1.35 | 37.3% | — |
| TBPH | Theravance Biopharma Inc | Healthcare | $16.86 | $869.18M | 8.21 | 2.99 | 36.4% | — |
| GILD | Gilead Sciences, Inc. - Common Stock | Healthcare | $130.21 | $161.66B | 19.00 | 6.87 | 36.2% | — |
| BMY | Bristol-Myers Squibb Company Common Stock | Healthcare | $65.31 | $133.37B | 18.91 | 6.65 | 35.2% | — |
| JNJ | Johnson & Johnson | Healthcare | $256.35 | $617.09B | 23.02 | 7.60 | 33.0% | — |
| CHE | Chemed Corp | Healthcare | $532.25 | $7.07B | 26.64 | 8.33 | 31.3% | — |
| NVS | Novartis AG Common Stock | Healthcare | $156.15 | $297.96B | 21.31 | 6.46 | 30.3% | — |
| DXCM | DexCom, Inc. - Common Stock | Healthcare | $83.45 | $32.20B | 38.50 | 10.89 | 28.3% | — |
| IRMD | iRadimed Corporation - Common Stock | Healthcare | $90.86 | $1.16B | 51.67 | 11.79 | 22.8% | — |
| UTHR | United Therapeutics Corporation - Common Stock | Healthcare | $517.71 | $21.98B | 16.46 | 3.72 | 22.6% | — |
| EHC | Encompass Health Corporation Common Stock | Healthcare | $111.07 | $11.02B | 19.46 | 4.37 | 22.5% | — |
| RMD | ResMed Inc. Common Stock | Healthcare | $210.98 | $30.60B | 21.85 | 4.71 | 21.6% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. - Common Stock | Healthcare | $31.49 | $3.85B | 17.98 | 3.81 | 21.2% | — |
| OGN | Organon & Co. Common Stock | Healthcare | $13.55 | $3.56B | 19.03 | 3.94 | 20.7% | — |
| MSA | MSA Safety Incorporated Common Stock | Healthcare | $190.27 | $7.35B | 26.33 | 5.42 | 20.6% | — |
| VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Healthcare | $477.10 | $121.09B | 30.63 | 6.25 | 20.4% | — |
| INVA | Innoviva, Inc. - Common Stock | Healthcare | $20.97 | $1.55B | 5.71 | 1.15 | 20.2% | — |
| COLL | Collegium Pharmaceutical, Inc. - Common Stock | Healthcare | $35.39 | $1.15B | 18.26 | 3.67 | 20.1% | — |